Article
Optimal COVID-19 Therapeutic Candidate Discovery Using the CANDO Platform
2022-04-26
Abstract excerpt
The worldwide outbreak of SARS-CoV-2 in early 2020 caused numer- ous deaths and unprecedented measures to control its spread. We employed our Computational Analysis of Novel Drug Opportunities (CANDO) multiscale therapeutic discovery, repurposing, and design platform to identify small molecule inhibitors of the virus to treat its resulting indication, COVID-19. Initially, few experimental studies existed on SARS-C...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 17b0325e-3c6e-5383-b95e-8b1a2f4d1e41
- DOI
- 10.20944/preprints202204.0224.v1
